Efficacy and Tolerability of a New HFA-Propelled Fluticasone/Formoterol Combination Inhaler Compared to Budesonide/Formoterol Combination in Subjects With Moderate to Persistent Asthma
Chest(2010)
摘要
PURPOSE: In patients of bronchial asthma not adequately controlled by inhaled corticosteroids (ICS) alone, the addition of long acting beta agonists is recommended. We evaluated the safety and efficacy of a new HFA propelled pressurized metered dose inhaler (pMDI) containing a combination of Fluticasone and Formoterol compared to the combination of Budesonide/Formoterol.
更多查看译文
关键词
fluticasone/formoterol combination inhaler,persistent asthma,fluticasone/formoterol combination,budesonide/formoterol,hfa-propelled
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要